- Home
- LMAT vs WKC Comparison
LMAT vs WKC Comparison
Compare LMAT & WKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMAT
- WKC
- Stock Information
- Founded
- LMAT 1983
- WKC 1984
- Country
- LMAT United States
- WKC United States
- Employees
- LMAT N/A
- WKC N/A
- Industry
- LMAT Medical/Dental Instruments
- WKC Oil Refining/Marketing
- Sector
- LMAT Health Care
- WKC Energy
- Exchange
- LMAT Nasdaq
- WKC Nasdaq
- Market Cap
- LMAT 1.8B
- WKC N/A
- IPO Year
- LMAT 2006
- WKC N/A
- Fundamental
- Price
- LMAT $83.05
- WKC $28.52
- Analyst Decision
- LMAT Buy
- WKC Hold
- Analyst Count
- LMAT 8
- WKC 5
- Target Price
- LMAT $97.00
- WKC $29.80
- AVG Volume (30 Days)
- LMAT 283.0K
- WKC 856.4K
- Earning Date
- LMAT 05-01-2025
- WKC 04-24-2025
- Dividend Yield
- LMAT 0.96%
- WKC 2.37%
- EPS Growth
- LMAT 44.03
- WKC 31.39
- EPS
- LMAT 1.93
- WKC 1.13
- Revenue
- LMAT $219,863,000.00
- WKC $42,168,000,000.00
- Revenue This Year
- LMAT $11.00
- WKC N/A
- Revenue Next Year
- LMAT $8.48
- WKC $3.77
- P/E Ratio
- LMAT $43.18
- WKC $25.35
- Revenue Growth
- LMAT 13.63
- WKC N/A
- 52 Week Low
- LMAT $62.39
- WKC $21.38
- 52 Week High
- LMAT $109.58
- WKC $31.71
- Technical
- Relative Strength Index (RSI)
- LMAT 39.01
- WKC 50.67
- Support Level
- LMAT $82.52
- WKC $27.86
- Resistance Level
- LMAT $85.50
- WKC $28.90
- Average True Range (ATR)
- LMAT 2.49
- WKC 0.60
- MACD
- LMAT 0.44
- WKC 0.03
- Stochastic Oscillator
- LMAT 53.32
- WKC 58.62
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.